# Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis

> **NCT04275232** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Dorothy Bautista, MD** · enrollment: 1 (estimated)

## Conditions studied

- Ligneous Conjunctivitis, Left Eye

## Interventions

- **BIOLOGICAL:** Allogenic plasma aliquots, a source of plasminogen

## Key facts

- **NCT ID:** NCT04275232
- **Lead sponsor:** Dorothy Bautista, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2024-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275232, "Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04275232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*